American Century Companies’s BioDelivery Sciences International, Inc. BDSI Stock Holding History

American Century Companies’s Portfolio BDSI Stock Details BDSI Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q1	–	Sell	-218,957	Closed	-$679K	–	2402
2021 Q4	$679K	Buy	218,957 +76,209	+53%	+$256K	﹤0.01%	1798
2021 Q3	$515K	Buy	142,748 +20,100	+16%	+$75.8K	﹤0.01%	1870
2021 Q2	$439K	Buy	+122,648	New	+$433K	﹤0.01%	1894
2015 Q1	–	Sell	-35,730	Closed	-$429K	–	1526
2014 Q4	$429K	Buy	+35,730	New	+$543K	﹤0.01%	1312
2013 Q3	–	Sell	-214,276	Closed	-$870K	–	1578
2013 Q2	$870K	Buy	+214,276	New	+$1.01M	﹤0.01%	1225

Other funds holding BDSI

CAM

Close Asset Management London, United Kingdom $3.76B AUM 40.74% 1-Year Est. Return

FCMT

Founders Capital Management (Texas) Houston, Texas $231M AUM 61.68% 1-Year Est. Return

American Century Companies's BDSI Position: Q1 2022 in Review

American Century Companies sold out of BioDelivery Sciences International, Inc. (BDSI) in Q1 2022, closing a stake of 218,957 shares — an estimated $679K sold.

American Century Companies first reported a position in BDSI in Q2 2013 and held it in 5 quarters. The position peaked at $870K in Q2 2013. 2 funds tracked by Wall St. Rank hold BDSI as of Q1 2022.

American Century Companies reported no remaining BioDelivery Sciences International, Inc. position as of Q1 2022 after selling out during the quarter.
American Century Companies sold 218,957 BioDelivery Sciences International, Inc. shares in Q1 2022, an estimated $679K.
American Century Companies first reported a position in BioDelivery Sciences International, Inc. in Q2 2013 and held it in 5 quarters.
American Century Companies's BioDelivery Sciences International, Inc. position peaked at $870K in Q2 2013.
2 funds tracked by Wall St. Rank held BioDelivery Sciences International, Inc. as of Q1 2022.

Based on American Century Companies's 13F filing for Q1 2022, filed 11 May 2022.